Detalles de la búsqueda
1.
Safety and efficacy of amlitelimab, a fully human nondepleting, noncytotoxic anti-OX40 ligand monoclonal antibody, in atopic dermatitis: results of a phase IIa randomized placebo-controlled trial.
Br J Dermatol
; 189(5): 531-539, 2023 10 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37463508
2.
A randomized controlled trial with a delayed-type hypersensitivity model using keyhole limpet haemocyanin to evaluate adaptive immune responses in man.
Br J Clin Pharmacol
; 87(4): 1953-1962, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33025648
3.
Use of continuous ECG for improvements in assessing the standing response as a positive control for QT prolongation.
Ann Noninvasive Electrocardiol
; 19(1): 82-9, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24460808
4.
OX40L Inhibition Suppresses KLH-driven Immune Responses in Healthy Volunteers: A Randomized Controlled Trial Demonstrating Proof-of-Pharmacology for KY1005.
Clin Pharmacol Ther
; 111(5): 1121-1132, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35092305
Resultados
1 -
4
de 4
1
Próxima >
>>